Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 12, 2008
Surgical outcomes of patients with gastrointestinal stromal tumors in the era of targeted drug therapyMehrdad Nikfarjam, Eric Kimchi, Serene Shereef, et al.
American Journal of Translational Research|July 18, 2019
PAK inhibition by PF-3758309 enhanced the sensitivity of multiple chemotherapeutic reagents in patient-derived pancreatic cancer cell linesKai Wang, Nhi Huynh, Xiao Wang, et al.
BMC Anesthesiology|May 20, 2014
The impact of fluid intervention on complications and length of hospital stay after pancreaticoduodenectomy (Whipple's procedure)Laurence Weinberg, Derrick Wong, Dharshi Karalapillai, et al.
ANZ Journal of Surgery|September 5, 2012
Outcomes of patients with histologically proven acute acalculous cholecystitisMehrdad Nikfarjam, Kiran Manya, Michael A Fink, et al.
World Journal of Surgical Oncology|December 1, 2025
Associations of early postoperative anemia with mortality and ICU outcomes in nonagenarians and centenarians undergoing colorectal cancer surgery: a binational multicenter propensity matching studyJe Min Suh, Laurence Weinberg, Jerry Lim, et al.
BMC Cancer|June 21, 2017
Depletion of p21-activated kinase 1 up-regulates the immune system of APC∆14/+ mice and inhibits intestinal tumorigenesisNhi Huynh, Kai Wang, Mildred Yim, et al.
ANZ Journal of Surgery|April 30, 2020
Population-based analysis of treatment patterns and outcomes for pancreas cancer in VictoriaCharles H C Pilgrim, Luc Te Marvelde, Ella Stuart, et al.
The Journal of Surgical Research|August 21, 2020
Prophylactic Negative-pressure Dressings Reduce Wound Complications and Resource Burden After Emergency LaparotomiesDavid S Liu, Chao Cheng, Rumana Islam, et al.
World Journal of Surgical Oncology|February 4, 2009
Diagnosis and management of retroperitoneal ancient schwannomasHaroon A Choudry, Mehrdad Nikfarjam, John J Liang, et al.
BMC Cancer|November 17, 2012
Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatmentsLinh Nguyen, Theodora Fifis, Caterina Malcontenti-Wilson, et al.
Pageof 16